Related Experiment Videos
Guillain-Barré syndrome: multifactorial mechanisms versus defined subgroups
F G van der Meché1, L H Visser, B C Jacobs
1Department of Neurology, Erasmus Medical Center Rotterdam, The Netherlands.
The Journal of Infectious Diseases
|December 13, 1997
Summary
Guillain-Barré syndrome (GBS) variants are linked to specific infections and antibodies. Early high-dose immunoglobulin therapy may be more effective for the pure motor GBS subtype with diarrhea and anti-GM1 antibodies.
Area of Science:
- Neurology
- Immunology
- Infectious Diseases
Background:
- Guillain-Barré syndrome (GBS) is a heterogeneous autoimmune disorder affecting peripheral nerves.
- Understanding the clinical spectrum and its associations is crucial for diagnosis and treatment.
Purpose of the Study:
- To summarize the clinical spectrum of GBS in relation to antecedent infections and anti-ganglioside antibodies.
- To explore potential differences in treatment response among GBS variants.
Main Methods:
- Review and summarization of existing clinical data.
- Correlation analysis between clinical presentations, preceding infections, and antibody profiles.
Main Results:
- Specific associations identified: pure motor GBS with diarrhea, Campylobacter jejuni, and anti-GM1 antibodies.
- Miller Fisher syndrome linked to cranial nerve involvement, C. jejuni, and anti-GQ1b antibodies.
- Severe sensory GBS variants associated with cytomegalovirus infection.
Conclusions:
- The three identified variants may represent extremes of a continuous GBS spectrum.
- Patients with pure motor GBS, diarrhea, and anti-GM1 antibodies show better response to high-dose immunoglobulins than plasma exchange.